These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 12760192)

  • 21. Warfarin, aspirin, or both after myocardial infarction.
    Pullicino P; Thompson JL
    N Engl J Med; 2003 Jan; 348(3):256-7; author reply 256-7. PubMed ID: 12529470
    [No Abstract]   [Full Text] [Related]  

  • 22. Combination antithrombotic therapy with antiplatelet agents and anticoagulants for patients with atherosclerotic heart disease.
    Arjomand H; Cohen M; Ezekowitz MD
    J Invasive Cardiol; 2004 May; 16(5):271-8. PubMed ID: 15152137
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epidemiology, risk factors for stroke, and management of atrial fibrillation in China.
    Hu D; Sun Y
    J Am Coll Cardiol; 2008 Sep; 52(10):865-8. PubMed ID: 18755352
    [No Abstract]   [Full Text] [Related]  

  • 24. [Secondary prevention of stroke].
    Shinohara Y
    No To Shinkei; 2004 Nov; 56(11):933-9. PubMed ID: 15678950
    [No Abstract]   [Full Text] [Related]  

  • 25. Antiplatelet drugs for ischemic stroke prevention.
    Leys D; Balucani C; Cordonnier C
    Cerebrovasc Dis; 2009; 27 Suppl 1():120-5. PubMed ID: 19342841
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anticoagulants for acute ischemic stroke.
    Berge E; Sandercock P
    Adv Neurol; 2003; 92():257-62. PubMed ID: 12760191
    [No Abstract]   [Full Text] [Related]  

  • 27. Why is WASID an important clinical trial?
    Hart RG
    Neuroepidemiology; 2003; 22(2):101-2. PubMed ID: 12656116
    [No Abstract]   [Full Text] [Related]  

  • 28. Aspirin vs anticoagulation in carotid artery dissection: a study of 298 patients.
    Georgiadis D; Arnold M; von Buedingen HC; Valko P; Sarikaya H; Rousson V; Mattle HP; Bousser MG; Baumgartner RW
    Neurology; 2009 May; 72(21):1810-5. PubMed ID: 19321846
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antiplatelet versus anticoagulant therapies in advanced age: an unfinished task.
    García-Honrubia A; Roldán V; Climent V; Sogorb F; Marín F
    Int J Cardiol; 2006 Jun; 110(2):271-2. PubMed ID: 16343666
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Medications used to prevent adhesion and clotting.
    Lassiter TF
    Lippincotts Prim Care Pract; 2000; 4(6):619-32; quiz 633-5. PubMed ID: 11933375
    [No Abstract]   [Full Text] [Related]  

  • 31. Atrial fibrillation and anticoagulation.
    Garnier LF; Rouesnel P; Espitalier F
    Arch Mal Coeur Vaiss; 2004 Oct; 97(10):1001-5. PubMed ID: 16008178
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of anticoagulation for secondary stroke prevention in older people with non-valvular atrial fibrillation: a prospective case series study.
    Tsivgoulis G; Spengos K; Zakopoulos N; Manios E; Peppes V; Vemmos K
    Age Ageing; 2005 Jan; 34(1):35-40. PubMed ID: 15591481
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Does the combination of warfarin and aspirin have a place in secondary stroke prevention? No.
    Fisher M
    Stroke; 2009 May; 40(5):1944-5. PubMed ID: 19299634
    [No Abstract]   [Full Text] [Related]  

  • 34. [Antithrombotic treatment in atrial fibrillation. Background to new recommendations and therapeutic alternative].
    Själander A; Wallentin L; Rosenqvist M; Svensson P
    Lakartidningen; 2008 Sep 10-16; 105(37):2478-80. PubMed ID: 19006862
    [No Abstract]   [Full Text] [Related]  

  • 35. Clinical inquiries. Does combining aspirin and warfarin decrease the risk of stroke for patients with nonvalvular atrial fibrillation?
    Robertson SL; Mayer JB; Guthmann R
    J Fam Pract; 2004 Jul; 53(7):570-5. PubMed ID: 15251100
    [No Abstract]   [Full Text] [Related]  

  • 36. What are the therapeutic options for strokes secondary to intracranial large artery stenosis?
    Khan M; Kamal AK
    J Pak Med Assoc; 2011 Feb; 61(2):194-5. PubMed ID: 21375179
    [No Abstract]   [Full Text] [Related]  

  • 37. Stroke and its prevention in chronic kidney disease.
    Khella S; Bleicher MB
    Clin J Am Soc Nephrol; 2007 Nov; 2(6):1343-51. PubMed ID: 17942760
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cost-effectiveness of warfarin: trial versus "real-world" stroke prevention in atrial fibrillation.
    Sorensen SV; Dewilde S; Singer DE; Goldhaber SZ; Monz BU; Plumb JM
    Am Heart J; 2009 Jun; 157(6):1064-73. PubMed ID: 19464418
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New developments in secondary stroke prevention: impact of the European/Australasian Stroke Prevention in Reversible Ischemia Trial (ESPRIT) on clinical management.
    Lutsep HL
    J Stroke Cerebrovasc Dis; 2007; 16(6):263-7. PubMed ID: 18035244
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Warfarin versus aspirin in patients with reduced cardiac ejection fraction (WARCEF): rationale, objectives, and design.
    Pullicino P; Thompson JL; Barton B; Levin B; Graham S; Freudenberger RS;
    J Card Fail; 2006 Feb; 12(1):39-46. PubMed ID: 16500579
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.